Corundum Systems Biology

Japanese investment firm specializing in systems biology and life sciences. Focus on computational approaches to drug discovery and therapeutics development, bridging Japanese innovation with global markets.

Location
Tokyo, Japan
Founded
2010
AUM
¥50B+
Investment Range
¥100M - ¥1B
Portfolio Companies
9
Focus
biotech-focused
Fund Stages
seed, series-a, series-b

Investment Thesis

Corundum Systems Biology invests in companies applying systems biology and computational approaches to life sciences challenges. They focus on bridging academic research with commercial applications, particularly in drug discovery and therapeutic development in Japan and globally.

Team

Partners / Managing Directors (Health & Bio Focus)

  • Investment team with systems biology expertise
  • Strong connections to Japanese academic institutions

Other Key Team Members

  • Scientific advisory network in computational biology

Focus Areas

  • Systems Biology
  • Computational Biology
  • Drug Discovery
  • Therapeutics
  • Life Sciences
  • Deep Tech
  • Japanese Life Sciences

Notable Exits

  • Portfolio companies advancing through Japanese and global markets
  • Focus on systems biology applications

Sources

Portfolio Companies

NameLocationFoundedCategories
VerteroBoston, Massachusetts, USA-
biotechsystems-biology+1
HolobiomeCambridge, Massachusetts, USA2015
biotechmicrobiome+2
Freya BiosciencesSouth San Francisco, California, USA2019
therapeuticsbiotech+2
Concerto BiosciencesCambridge, Massachusetts, USA2020
microbiometherapeutics+3
SequentialSan Francisco, California, USA2019
microbiomediagnostics+2
KulaOmicsSingapore2019
genomicsmulti-omics+3
Pheno.AITel Aviv, Israel2019
ai-drug-discoveryhealthcare-platform+2
ImYooBoston, Massachusetts, USA2019
biotechhealthcare+1
Nimble Science--
biotechsystems-biology+1